Therapeutic Biologics Research
Exponential power to engineer novel therapeutics
From early discovery through development, MindWalk integrates Bio-Native AI, deep data, and advanced lab research into a customizable ecosystem engineered to support precision, deepen diversity, and enable confident discovery.
Workflows built for complex discovery
Contributed to advancing 15+ clinical candidates
Precision biologic insight driven by AI, data, and advanced lab research—designed to bring blind spots into view and support complex discovery programs.
Continuity, seamless handoffs
One workflow bridging target analysis to IND-enabling readiness
Stronger starts
Risk considerations brought forward early to help avoid costly late-stage surprises
360° intelligence with transparent insight
Powered by LensAI™, integrated biological and functional data provide a transparent, explainable view of each candidate’s strengths and areas of uncertainty
A customizable ecosystem
No two programs are alike. Our approach adapts to your challenges with diversity-driven workflows designed to surface rare candidates with strong translational potential and support more targeted experimental design.
One system + Connected intelligence + Transformative insight
Speed
- Stronger starts
- Reduced time to lead selection
Integrated workflows help flag areas of potential risk earlier
Diversity
- Rare, high-value candidates brought into focus
- Deep insight across phenotypic diversity highlights patterns not visible in isolated data
Broad, connected datasets add depth—revealing opportunities across discovery programs
Confidence
- Evidence-based discovery
- Contributed to programs supporting 15+ clinical candidates
- >98% B cell Select™ success rate*
Deep biological data and predictive modeling bring risk considerations forward
*“Success” refers to meeting predefined discovery criteria, not clinical or therapeutic outcomes. Results may vary.
Speed
- Stronger starts
- Reduced time to lead selection
Integrated workflows help flag areas of potential risk earlier
Diversity
- Rare, high-value candidates brought into focus
- Deep insight across phenotypic diversity highlights patterns not visible in isolated data
Broad, connected datasets add depth—revealing opportunities across discovery programs
Confidence
- Evidence-based discovery
- Contributed to programs supporting 15+ clinical candidates
- >98% B cell Select™ success rate*
Deep biological data and predictive modeling bring risk considerations forward
*“Success” refers to meeting predefined discovery criteria, not clinical or therapeutic outcomes. Results may vary.
Revealing what was once unseen
Every discovery holds hidden biologic patterns that reveal what to pursue, refine, or reimagine. MindWalk integrates intelligent analysis with experimental depth to interpret those patterns—an approach designed to support the development of differentiated therapeutic candidates.
Your success is our success
Collaboration drives every project. We listen, adapt, and align with your goals, applying scientific and technological rigor with advanced workflows to deliver reliable insights and support progress. For us, success is measured by the progress of your discoveries.
“LensAI solves a foundational problem—making biological data interoperable and accessible at scale. It brings context into view, giving us the kind of resolution you’d expect from modern data systems—and that changes everything.” - Jeff Fried, Advisory Board Member, MindWalk
Where our research makes a broad impact
Oncology + Infectious Disease + Neurodegeneration + Metabolic Disease + Rare Disease + Inflammation + Market Kits
Biologics discovery across complex targets
Contributed to 15+ molecules advancing to the clinic
Antibody discovery + development
LensAI Bio-Native Suite:
- HYFT Base™ Data Integration and Insights: Target Profiling, Off-target & Cross-reactivity, Antigen Design, Epitope Prediction, Epitope Specificity Analysis, Protein Structure Prediction, GMX (MD Applications)
- HYFT Matrix™ Exploration Layer: Epitope Mapping, Affinity Predictions (MD), Hit Selection, Developability Assessment, Immunogenicity Screening, Hit Expansion
- HYFT Prime™ Engineering and Design Engine: Humanization, De-risk Engineering, Binding Affinity Optimization, Target Specificity and Selectivity
Integrated Therapeutic Discovery AI/Data/Lab:
Target
- Target Analysis
- Tool Generation
- HYFT Base
Discovery
- Immunization Strategies
- B cell Select®, Hybridoma and Yeast Display Discovery
- De novo Design
- HYFT Matrix & HYFT Prime
Leads
- Lead Characterization
- Lead Optimization
- Protein Engineering and Production
- HYFT Matrix & HYFT Prime
Candidate Selection
- Research Cell Bank Generation
Functional selection
- Internalization
- Neutralization
- Epitope Mapping
- Affinity, Specificity, Developability
- Custom Cell-based and Plate-based Assays
Species Diversity
Rabbit + Chicken + Camelid + Mice
Immunization Strategies
Protein + Genetic + Peptide + Whole Cell
Format Options
- Full-length IgG
- Bispecific Antibodies (bsAbs)
- VHH / Nanobody
- scFv, Fab, F(ab’)2
- Custom Formats
- Fusion Constructs
Expanding discovery innovation
Vaccines + Peptide Therapies + Cell Therapies + Other Biologics
Let’s shape the future
One biointelligent ecosystem,
explore partnership opportunities
Used by teams across 19 of the top 20 pharma companies, next-gen biotechs, and top research institutions.
Take the first step
Let’s expand what’s possible for human health
Four ways to access MindWalk
We build it
Customizable offerings in biologics discovery—from target analysis to optimized leads.
You build it
Access to state-of-the-art LensAI SaaS Platform.
The Vault
Smarter starts: a portfolio of partner-ready assets.
Partnership
We are proud to partner with the best in pharma, biotech and academia organizations. Join us in creating future of human health.